Department of Urology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Int J Urol. 2022 Jun;29(6):559-565. doi: 10.1111/iju.14846. Epub 2022 Mar 13.
To compare the perioperative outcomes between thrombectomy first then nephrectomy ("thrombus-first") and vice-versa ("thrombus-last") approaches for patients with renal cell carcinoma and inferior vena cava thrombus.
We retrospectively evaluated 130 patients who underwent nephrectomy and thrombectomy at two institutions between 1992 and 2020. The cohort was classified into the thrombus-first and thrombus-last groups according to the techniques used. Outcomes including the operative time, blood loss, and complications, especially the occurrence of intraoperative tumor embolism of pulmonary artery and postoperative pulmonary embolism, were compared.
The thrombus-first and thrombus-last groups comprised 48 and 82 patients, respectively. Characteristics such as age, performance status, Charlson Comorbidity Index, renal function, and level of tumour thrombus were comparable between the two groups. Approximately 41% of the patients had distant metastasis. There were four cases (3.1%) of intraoperative tumor embolism, all from the thrombus-last group. Three patients overall (2.3%) experienced pulmonary embolism postoperatively with two in the thrombus-last group (2.4%) and one in the thrombus-first group (2.1%) (P > 0.999). The surgical time (291.0 min vs 369.0 min, P < 0.001) and the blood loss (1323.0 vs 2100.0 mL, P < 0.001) were significantly smaller for the thrombus-first group than for the thrombus-last group. Occurrence of complications was 25.0% and 43.9% in thrombus-first and thrombus-last groups, respectively (P = 0.029), and 8.3% and 23.2% for events graded ≥3 (P = 0.035).
In surgery for renal cell carcinoma with inferior vena cava thrombus, performing thrombectomy before nephrectomy may serve to lessen complications, blood loss, and surgical time compared to nephrectomy before thrombectomy.
比较肾细胞癌合并下腔静脉癌栓患者先行血栓切除术再行肾切除术(“血栓优先”)与先行肾切除术再行血栓切除术(“血栓滞后”)的围手术期结局。
我们回顾性评估了 1992 年至 2020 年期间在两个机构接受肾切除术和血栓切除术的 130 例患者。根据使用的技术,将队列分为血栓优先组和血栓滞后组。比较了手术时间、出血量和并发症等结局,特别是术中肺动脉肿瘤栓塞和术后肺栓塞的发生情况。
血栓优先组和血栓滞后组分别包括 48 例和 82 例患者。两组患者的年龄、体力状态、Charlson 合并症指数、肾功能和肿瘤血栓水平等特征相似。约 41%的患者存在远处转移。有 4 例(3.1%)术中肿瘤栓塞,均来自血栓滞后组。总体有 3 例(2.3%)患者术后发生肺栓塞,其中血栓滞后组 2 例(2.4%),血栓优先组 1 例(2.1%)(P > 0.999)。血栓优先组的手术时间(291.0 min 比 369.0 min,P < 0.001)和出血量(1323.0 mL 比 2100.0 mL,P < 0.001)明显小于血栓滞后组。血栓优先组并发症发生率为 25.0%,血栓滞后组为 43.9%(P = 0.029),≥3 级事件发生率为 8.3%和 23.2%(P = 0.035)。
在下腔静脉癌栓合并肾细胞癌的手术中,与先肾切除术再血栓切除术相比,先血栓切除术再肾切除术可能会减少并发症、出血量和手术时间。